ResQCPR System


The ResQCPR™ System is a CPR adjunct comprised of two synergistic devices—the ResQPOD® ITD 16 and the CardioPump® ACD-CPR Device. Together, they increase the likelihood of survival. A major clinical study of more than 1600 patients showed a 49% increase in one-year survival from cardiac arrest.1

  • The ResQPOD ITD 16 returns more blood to the heart (preload) and lowers intracranial pressure by regulating airflow during CPR to increase the vacuum in a patient’s chest during chest wall recoil.2,3
  • The CardioPump ACD-CPR device further increases blood return by re-expanding the chest with a lift force of up to 10 kg. It is the only approved system for delivering true active compression-decompression CPR.

1In adults with cardiac arrest from cardiac etiology. ResQCPR System Summary of Safety and Effectiveness Data submitted to FDA.
2Metzger, A, et al. Crit Care Med. 2012; 40(6):1851-1856.
3Voelckel W, et al. Pediatr Res. 2002;51:523-527.